Literature DB >> 8144564

Identification, partial purification, and characterization of a novel phospholipid-dependent and fatty acid-activated protein kinase from human platelets.

W A Khan1, G C Blobe, A L Richards, Y A Hannun.   

Abstract

A novel lipid-dependent protein kinase in human platelets was partially purified and characterized. This enzyme was calcium-independent and was selective for phosphatidic acid as a cofactor/activator with initial activation observed at approximately 2 mol % and peak activity achieved at 4 mol % phosphatidic acid. In the presence of phosphatidylserine, enzyme activation was observed with concentrations of phosphatidic acid as low as 0.5 mol % with peak activity at 2 mol %. Other anionic phospholipids also activated the enzyme but to a lesser extent and with less potency. Enzyme activity was independent of diacylglycerol or phorbol esters and the enzyme did not bind [3H]phorbol dibutyrate. In a soluble protein kinase assay, the enzyme was activated by cis-unsaturated fatty acids with maximum activation occurring at 5-10 microM sodium oleate. Western blot analysis showed that this enzyme did not cross-react immunologically with antibodies raised against the currently identified isoenzymes of protein kinase C. A number of additional biochemical criteria distinguished this enzyme from known isoenzymes of protein kinase C. These biochemical and immunologic data define a novel lipid-dependent protein kinase in human platelets. The role of this enzyme in signal transduction as a phosphatidic acid-activated enzyme and as a possible target for cis-unsaturated fatty acids is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144564

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Increased phospholipase D activity in human breast cancer.

Authors:  N Uchida; S Okamura; Y Nagamachi; S Yamashita
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 2.  Features of the Phosphatidylinositol Cycle and its Role in Signal Transduction.

Authors:  Richard M Epand
Journal:  J Membr Biol       Date:  2016-06-08       Impact factor: 1.843

3.  Molecular and behavioral characterization of adolescent protein kinase C following high dose ethanol exposure.

Authors:  Jessica L Santerre; Eduardo D Gigante; Justine D Landin; David F Werner
Journal:  Psychopharmacology (Berl)       Date:  2013-09-20       Impact factor: 4.530

4.  Purification and characterization of a fatty acid-activated protein kinase (PKN) from rat testis.

Authors:  M Kitagawa; H Mukai; H Shibata; Y Ono
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

5.  Characterization of Saccharomyces cerevisiae deficient in expression of phospholipase D.

Authors:  K M Ella; J W Dolan; C Qi; K E Meier
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

6.  Cell-free activation of neutrophil NADPH oxidase by a phosphatidic acid-regulated protein kinase.

Authors:  L C McPhail; D Qualliotine-Mann; K A Waite
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanism.

Authors:  E A Martinson; S Scheible; A Greinacher; P Presek
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

8.  G Protein Activation Stimulates Phospholipase D Signaling in Plants.

Authors:  T. Munnik; S. A. Arisz; T. De Vrije; A. Musgrave
Journal:  Plant Cell       Date:  1995-12       Impact factor: 11.277

9.  A 104-kDa diacylglycerol kinase containing ankyrin-like repeats localizes in the cell nucleus.

Authors:  K Goto; H Kondo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 10.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.